Northwest Biotherapeutics Inc (NWBO)
0.4659
+0.01
(+1.29%)
USD |
OTCM |
May 02, 16:19
Northwest Biotherapeutics Free Cash Flow: -57.07M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -57.07M |
| September 30, 2023 | -50.71M |
| June 30, 2023 | -52.74M |
| March 31, 2023 | -55.22M |
| December 31, 2022 | -55.68M |
| September 30, 2022 | -57.47M |
| June 30, 2022 | -50.78M |
| March 31, 2022 | -43.83M |
| December 31, 2021 | -44.31M |
| September 30, 2021 | -44.78M |
| June 30, 2021 | -45.34M |
| March 31, 2021 | -44.61M |
| December 31, 2020 | -38.70M |
| September 30, 2020 | -31.53M |
| June 30, 2020 | -27.74M |
| March 31, 2020 | -29.90M |
| December 31, 2019 | -32.22M |
| September 30, 2019 | -40.30M |
| June 30, 2019 | -37.88M |
| March 31, 2019 | -39.71M |
| December 31, 2018 | -34.59M |
| September 30, 2018 | -35.20M |
| June 30, 2018 | -36.87M |
| March 31, 2018 | -29.01M |
| December 31, 2017 | -36.50M |
| Date | Value |
|---|---|
| September 30, 2017 | -35.98M |
| June 30, 2017 | -40.47M |
| March 31, 2017 | -52.60M |
| December 31, 2016 | -60.59M |
| September 30, 2016 | -72.30M |
| June 30, 2016 | -75.87M |
| March 31, 2016 | -88.02M |
| December 31, 2015 | -86.46M |
| September 30, 2015 | -90.48M |
| June 30, 2015 | -107.50M |
| March 31, 2015 | -96.46M |
| December 31, 2014 | -88.30M |
| September 30, 2014 | -72.86M |
| June 30, 2014 | -50.02M |
| March 31, 2014 | -41.28M |
| December 31, 2013 | -37.80M |
| September 30, 2013 | -31.50M |
| June 30, 2013 | -29.67M |
| March 31, 2013 | -26.32M |
| December 31, 2012 | -22.78M |
| September 30, 2012 | -19.11M |
| June 30, 2012 | -18.11M |
| March 31, 2012 | -16.80M |
| December 31, 2011 | -14.76M |
| September 30, 2011 | -10.33M |
Free Cash Flow Range, Past 5 Years
-57.47M
Minimum
Sep 2022
-27.74M
Maximum
Jun 2020
-44.25M
Average
-44.61M
Median
Mar 2021
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.96M |
| Cash from Investing (Quarterly) | -0.418M |
| Cash from Financing (Quarterly) | 14.42M |
| Free Cash Flow Per Share (Quarterly) | -0.015 |
| Free Cash Flow to Equity (Quarterly) | -25.23M |
| Free Cash Flow Yield | -10.95% |